Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone.
We report a case of a virilized 59-yr-old woman with elevated serum testosterone levels and bilateral macronodular adrenal hyperplasia. The patient underwent laparoscopic right adrenalectomy, after which the elevated testosterone level transiently normalized. The immediate postoperative depression of the testosterone level suggested that the process was driven by gonadotropins that were suppressed by the stress of surgery. The excised right adrenal mass contained testosterone by immunohistochemistry and LH receptor mRNA by in situ hybridization. The recurrence of hyperandrogenemia suggested that the enlarged left adrenal was also secreting testosterone. The serum testosterone level increased in response to im injection of human chorionic gonadotropin, suggesting control by aberrant LH receptors. Injection of leuprolide acetate (7.5 mg im) to suppress LH levels resulted in normalization of the testosterone level 12 d later that persisted for several weeks. Ectopic receptors mediating Cushing's syndrome have been described in several cases of bilateral adrenal hyperplasia and adrenal adenoma. This is the first case to our knowledge in which pure androgen overproduction in adrenal hyperplasia has been shown to be controlled by LH receptors. In our patient, the control of androgen secretion by LH may explain the postmenopausal onset of virilization and the transient postoperative normalization of the serum testosterone level.
Goodarzi
Mark O
MO
Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine and Gonda Diabetes Center, University of California Los Angeles School of Medicine, Los Angeles, California 90095, USA. mgoodarzi@mednet.ucla.edu
Dawson
David W
DW
Li
Xian
X
Lei
Zhenmin
Z
Shintaku
Peter
P
Rao
Chalama V
CV
Van Herle
Andre J
AJ
D000307:Adrenal Gland Diseases / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism* / Q000601:surgery; D000311:Adrenal Glands / Q000378:metabolism; D000315:Adrenalectomy; D005260:Female; D006801:Humans; D017588:Hyperandrogenism / Q000209:etiology; D007273:Injections, Intramuscular; D016729:Leuprolide / Q000008:administration & dosage / Q000627:therapeutic use; D007986:Luteinizing Hormone / Q000037:antagonists & inhibitors / Q000378:metabolism*; D008875:Middle Aged; D012333:RNA, Messenger / Q000378:metabolism; D011974:Receptors, LH / Q000235:genetics / Q000378:metabolism; D013739:Testosterone / Q000097:blood / Q000378:metabolism; D014770:Virilism / Q000209:etiology*
D012333:RNA, Messenger; D011974:Receptors, LH; D013739:Testosterone; D007986:Luteinizing Hormone; D016729:Leuprolide